Advertisement

The Latest

Hospital leaders are bracing for pediatric residency changes that could reshape the hospital workforce, a recent study found. The study, published May 27 in Hospital Pediatrics, surveyed pediatric hospital medicine leaders at 101 hospitals. The survey asked about leaders’ staffing…

The FDA has alerted patients who had mammograms at Mammography Center of Monterey (Calif.) on or after Dec. 22, 2023, to possible quality problems with their mammograms. The facility failed an additional mammography review, with some deficiencies in clinical image…

McKesson said a cybersecurity incident involving unauthorized access to third-party applications and data exfiltration affected a subset of customers within two of its business units. The Irving, Texas-based company said in an Aug. 29 cybersecurity update that the incident was…

Hospital consolidation is picking up steam, and the most notable deals moving through the pipeline are not incremental bolt-ons. They are multibillion-dollar combinations spanning states, reshuffling metro markets and pulling once-independent flagships under national and super-regional banners. Some are cross-country…

When LeWanza Harris, MD, chief quality officer of Atlanta-based Emory Healthcare, dug deeper into the system’s sepsis data last year, the metrics told a story of fragmentation across the system’s 11 hospitals. “The performance was inconsistent and in places low,”…

Indianapolis-based Eli Lilly has signed a definitive agreement to acquire Cambridge, Mass.-based Merida Biosciences, a biotechnology company aimed at advancing therapeutics for serious autoimmune and allergic diseases, for up to $2.875 billion in cash. The transaction includes an upfront payment…

For pharmacy and clinical informatics leaders, the “build-versus-buy” conundrum has become the default starting point for AI technology decisions. In medication workflows, however, that framing is incomplete. Whether an organization builds internally, buys from a vendor, or extends its EHR,…

In this episode, Matt Zarcufsky, Executive Director and Chief Philanthropy Officer of Tower Cancer Research Foundation, discusses funding early-stage cancer research, expanding patient support and adapting philanthropy to changing donor trends. He also shares his outlook on emerging cancer treatments,…

Advertisement